Skip to main content
. 2017 Sep 22;8(60):101345–101361. doi: 10.18632/oncotarget.21167

Figure 5. HOXA9 is a target of miR-182.

Figure 5

(A) Predicted binding site of miR-182 in the HOXA9 3′UTR; (B) Comparison of luciferase activity in the NC and miR-182 mimic groups; *P < 0.05, compared to the NC group.